Chang JT - Search Results

1

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.

Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, Goh BC, Chang JT, Thiery JP, Mori S. Tan TZ, et al. Among authors: chang jt. EMBO Mol Med. 2013 Jul;5(7):1051-66. doi: 10.1002/emmm.201201823. Epub 2013 May 13. EMBO Mol Med. 2013. PMID: 23666744 Free PMC article.

2

Yin yang 1 modulates taxane response in epithelial ovarian cancer.

Matsumura N, Huang Z, Baba T, Lee PS, Barnett JC, Mori S, Chang JT, Kuo WL, Gusberg AH, Whitaker RS, Gray JW, Fujii S, Berchuck A, Murphy SK. Matsumura N, et al. Among authors: chang jt. Mol Cancer Res. 2009 Feb;7(2):210-20. doi: 10.1158/1541-7786.MCR-08-0255. Epub 2009 Feb 10. Mol Cancer Res. 2009. PMID: 19208743 Free PMC article.

3

A genomic strategy to elucidate modules of oncogenic pathway signaling networks.

Chang JT, Carvalho C, Mori S, Bild AH, Gatza ML, Wang Q, Lucas JE, Potti A, Febbo PG, West M, Nevins JR. Chang JT, et al. Mol Cell. 2009 Apr 10;34(1):104-14. doi: 10.1016/j.molcel.2009.02.030. Mol Cell. 2009. PMID: 19362539 Free PMC article.

4

Anchorage-independent cell growth signature identifies tumors with metastatic potential.

Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G, Kim JW, Gatza M, Murphy S, Nevins JR. Mori S, et al. Among authors: chang jt. Oncogene. 2009 Aug 6;28(31):2796-805. doi: 10.1038/onc.2009.139. Epub 2009 Jun 1. Oncogene. 2009. PMID: 19483725 Free PMC article.

5

Utilization of genomic signatures to identify phenotype-specific drugs.

Mori S, Chang JT, Andrechek ER, Potti A, Nevins JR. Mori S, et al. Among authors: chang jt. PLoS One. 2009 Aug 28;4(8):e6772. doi: 10.1371/journal.pone.0006772. PLoS One. 2009. PMID: 19714244 Free PMC article.

6

Using a stem cell-based signature to guide therapeutic selection in cancer.

Shats I, Gatza ML, Chang JT, Mori S, Wang J, Rich J, Nevins JR. Shats I, et al. Among authors: chang jt. Cancer Res. 2011 Mar 1;71(5):1772-80. doi: 10.1158/0008-5472.CAN-10-1735. Epub 2010 Dec 17. Cancer Res. 2011. PMID: 21169407 Free PMC article.

7

A method of sample-wise region-set enrichment analysis for DNA methylomics.

Minegishi R, Gotoh O, Tanaka N, Maruyama R, Chang JT, Mori S. Minegishi R, et al. Among authors: chang jt. Epigenomics. 2021 Jul;13(14):1081-1093. doi: 10.2217/epi-2021-0065. Epub 2021 Jul 9. Epigenomics. 2021. PMID: 34241544

8

Patterns of cell signaling pathway activation that characterize mammary development.

Andrechek ER, Mori S, Rempel RE, Chang JT, Nevins JR. Andrechek ER, et al. Among authors: chang jt. Development. 2008 Aug;135(14):2403-13. doi: 10.1242/dev.019018. Epub 2008 Jun 11. Development. 2008. PMID: 18550711 Free PMC article.

9

Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma.

Mori S, Rempel RE, Chang JT, Yao G, Lagoo AS, Potti A, Bild A, Nevins JR. Mori S, et al. Among authors: chang jt. Cancer Res. 2008 Oct 15;68(20):8525-34. doi: 10.1158/0008-5472.CAN-08-1329. Cancer Res. 2008. PMID: 18922927 Free PMC article.

10

A pharmacogenomic method for individualized prediction of drug sensitivity.

Cohen AL, Soldi R, Zhang H, Gustafson AM, Wilcox R, Welm BE, Chang JT, Johnson E, Spira A, Jeffrey SS, Bild AH. Cohen AL, et al. Among authors: chang jt. Mol Syst Biol. 2011 Jul 19;7:513. doi: 10.1038/msb.2011.47. Mol Syst Biol. 2011. PMID: 21772261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

720 results

Search Page